Bayer

Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Endpoints
Mon, 06/24/19 - 11:25 am
Bristol-Myers Squibb
Opdivo
Bayer
Nexavar
liver cancer
clinical trials
Bayer begins phase 3 trial testing aflibercept in infant blindness
Pharmaforum
Mon, 06/24/19 - 09:39 am
Bayer
clinical trials
infant blindness
Aflibercept
retinopathy of prematurity
Bayer’s regorafenib kicks off brain cancer platform trial
Pharmaforum
Thu, 06/20/19 - 09:50 am
Bayer
brain cancer
clinical trials
GBM
regorafenib
FDA Received 6,000 Reports About Essure in 2018
Medical Devices and Diagnostics Industry
Fri, 06/14/19 - 10:10 am
devices
FDA
Essure
Bayer
contraceptives
Bayer inks Arvinas deal to develop protein degraders
Fierce Biotech
Tue, 06/4/19 - 11:56 am
Bayer
Arvinas
targeted protein degradation
Bayer's €8B animal health sale stirs up private equity shoppers: FT
Fierce Pharma
Mon, 06/3/19 - 12:42 pm
Bayer
animal health
M&A
CVC
Cinven
Permira
Bayer to work with Foundation Medicine on selecting cancer patients
Reuters
Wed, 05/29/19 - 11:01 pm
Bayer
Foundation Medicine
Roche
cancer
Vitrakvi
genetic sequencing
Bayer’s Aliqopa gets speedy review for marginal zone lymphoma
Pharmaforum
Wed, 05/29/19 - 09:54 am
Bayer
Aliqopa
FDA
breakthrough therapy
marginal zone lymphoma
Don't Overreact to the $2 Billion Punitive Damages Award Against Bayer
Motley Fool
Tue, 05/28/19 - 11:19 pm
Bayer
California
Monsanto
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
BioCentury
Fri, 05/17/19 - 10:05 am
Roche
Bayer
brain cancer
entrectinib
Vitrakvi
FDA Updates on Essure Postmarketing Study
RAPS.org
Thu, 05/16/19 - 10:01 am
Bayer
Essure
FDA
contraceptives
post-marketing studies
FDA approves Regeneron’s Eylea for diabetic retinopathy
Pharmaforum
Tue, 05/14/19 - 09:58 am
Regeneron
Eylea
diabetic retinopathy
FDA
Bayer
Bayer kicks off a $150M add-on for its campus in Berkeley
Endpoints
Thu, 05/9/19 - 11:12 pm
Bayer
drug manufacturing
Bay Area
Berkley
FDA tags Bayer's prostate cancer drug for priority review as drugmaker gears up against rivals
Endpoints
Mon, 04/29/19 - 12:02 pm
Bayer
Orion
prostate cancer
priority review
daralutamide
FDA
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Tue, 04/23/19 - 12:10 pm
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT
Endpoints
Tue, 04/9/19 - 08:29 am
Bayer
R&D
layoffs
Cambridge MA
MIT
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Bayer, after cyberattack, finds 'no evidence' hackers obtained data
Fierce Pharma
Thu, 04/4/19 - 11:00 pm
Bayer
cyberattack
hacking
cybersecurity
Bayer posts early clinical data on follow-up to Loxo’s Vitrakvi
Fierce Biotech
Mon, 04/1/19 - 09:37 pm
Bayer
Loxo Oncology
solid tumors
AACR
Bayer loses bid to toss some claims in Essure class action suit
Mass Device
Thu, 03/28/19 - 07:58 pm
Bayer
Essure
devices
contraceptives

Pages